Abeona Therapeutics Inc vs Figs Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Figs Inc trades at $14.26 (market cap $2.37B). The key difference: Figs Inc is far larger — about 5.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Figs Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | FIGS | |
|---|---|---|
Market Cap | $421.19M | $2.37B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $17.12 |
52-Week Low | $4.17 | $6.57 |
Enterprise Value | $276.10M | $2.13B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →